Quantcast

Industry news that matters to you.  Learn more

Archives for January 2013

In-vivo Study Shows CK1D Inhibitors Improve Cognition in Alzheimer’s Model

Proteome Sciences is pleased to announce that the in-vivo study of its proprietary CK1D inhibitor programme in Alzheimer’s disease was completed as anticipated in December 2012.

Thomas Jefferson University Researchers Discover New Pathways that Drive Metastatic Prostate Cancer

Elevated levels of Cyclin D1b could function as a novel biomarker of lethal metastatic disease in prostate cancer patients, according to a pre-clinical study published ahead of print on December 21 in the Journal of Clinical Investigation by researchers at the Kimmel Cancer Center at Jefferson.

Mayo Clinic Receives Funding for Gut Function Biomarker Research

Mayo Clinic announced today that it will receive funding through the Biomarkers of Gut Function and Health program within the Grand Challenges in Global Health initiative. This initiative was launched by the Bill & Melinda Gates Foundation to overcome persistent bottlenecks preventing the creation of new and better health solutions for the developing world. William Faubion, M.D., a Mayo Clinic gastroenterologist, will continue to pursue a research project titled “Gut Permeability in Environmental Enteropathy.”